ABL1 and myeloproliferative disorder: BCR-ABL-negative myeloproliferative neoplasms (Ph− MPN) make up a various set of hematologic malignancies, comprising polycythaemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF).